Wit FWNM - Search Results

1

Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.

Kooij KW, Vogt L, Wit FWNM, van der Valk M, van Zoest RA, Goorhuis A, Prins M, Post FA, Reiss P; AGEhIV Cohort Study. Kooij KW, et al. Among authors: wit fwnm. J Infect Dis. 2017 Sep 15;216(6):622-631. doi: 10.1093/infdis/jix202. J Infect Dis. 2017. PMID: 28934420

2

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.

Wit FW, Weverling GJ, Weel J, Jurriaans S, Lange JM. Wit FW, et al. J Infect Dis. 2002 Jul 1;186(1):23-31. doi: 10.1086/341084. Epub 2002 Jun 14. J Infect Dis. 2002. PMID: 12089658

3

CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.

Wit FW, van Rij RP, Weverling GJ, Lange JM, Schuitemaker H. Wit FW, et al. J Infect Dis. 2002 Dec 15;186(12):1726-32. doi: 10.1086/345677. Epub 2002 Nov 22. J Infect Dis. 2002. PMID: 12447757

4

When to Start Antiretroviral Therapy and What to Start With-- A European Perspective.

Wit FW, Reiss P. Wit FW, et al. Curr Infect Dis Rep. 2003 Aug;5(4):349-357. doi: 10.1007/s11908-003-0013-y. Curr Infect Dis Rep. 2003. PMID: 12866987

5

Nelfinavir plasma concentrations are low during pregnancy.

Nellen JF, Schillevoort I, Wit FW, Bergshoeff AS, Godfried MH, Boer K, Lange JM, Burger DM, Prins JM. Nellen JF, et al. Clin Infect Dis. 2004 Sep 1;39(5):736-40. doi: 10.1086/422719. Epub 2004 Aug 16. Clin Infect Dis. 2004. PMID: 15356791

6

Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.

Wit FW, Kesselring AM, Gras L, Richter C, van der Ende ME, Brinkman K, Lange JM, de Wolf F, Reiss P. Wit FW, et al. Clin Infect Dis. 2008 Mar 15;46(6):933-40. doi: 10.1086/528861. Clin Infect Dis. 2008. PMID: 18271750 Clinical Trial.

7

High prevalence of reduced bone mineral density in primary HIV-1-infected men.

Grijsen ML, Vrouenraets SM, Steingrover R, Lips P, Reiss P, Wit FW, Prins JM. Grijsen ML, et al. AIDS. 2010 Sep 10;24(14):2233-8. doi: 10.1097/QAD.0b013e32833c93fe. AIDS. 2010. PMID: 20616695

8

Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.

Vrouenraets SM, Fux CA, Wit FW, Garcia EF, Furrer H, Brinkman K, Hoek FJ, Abeling NG, Krediet RT, Reiss P; Prepare Study Group. Vrouenraets SM, et al. AIDS. 2011 Nov 13;25(17):2149-55. doi: 10.1097/QAD.0b013e32834bba87. AIDS. 2011. PMID: 21857491

9

A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function.

Vrouenraets SM, Fux CA, Wit FW, Garcia EF, Brinkman K, Hoek FJ, van Straalen JP, Furrer H, Krediet RT, Reiss P; Prepare Study Group. Vrouenraets SM, et al. Clin Nephrol. 2012 Apr;77(4):311-20. doi: 10.5414/cn107214. Clin Nephrol. 2012. PMID: 22445475 Clinical Trial.

10

Low bone mineral density, regardless of HIV status, in men who have sex with men.

Grijsen ML, Vrouenraets SM, Wit FW, Stolte IG, Prins M, Lips P, Reiss P, Prins JM. Grijsen ML, et al. J Infect Dis. 2013 Feb 1;207(3):386-91. doi: 10.1093/infdis/jis687. Epub 2012 Nov 12. J Infect Dis. 2013. PMID: 23148289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters